Liren Jiang

Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer

Siteng Chen, Liren Jiang, Xinyi Zheng et al. · Cancer Science · 2021 · 101 citations · Full text

Medicine, Oncology, Pathology +17

Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma

Siteng Chen, Liren Jiang, Feng Gao et al. · British Journal of Cancer · 2021 · 80 citations · Full text

Medicine, Bioinformatics, Oncology +16

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis

Liren Jiang, Joanna Zawacka‐Pankau · Cell Death and Disease · 2020 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +14

Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma

Siteng Chen, Ning Zhang, Liren Jiang et al. · International Journal of Cancer · 2020 · 64 citations

Medicine, Oncology, Pathology +17

PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions

Liren Jiang, Ning Zhang, Siteng Chen et al. · Frontiers in Oncology · 2021 · 62 citations · Full text

Medicine, Immunology, Oncology +17